Supplementary Materials

Supplementary Material for:

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

Emily P. Thi, Chad E. Mire, Raul Ursic-Bedoya, Joan B. Geisbert, Amy C. H. Lee, Krystle N. Agans, Marjorie Robbins, Daniel J. Deer, Karla A. Fenton, Ian MacLachlan,* Thomas W. Geisbert*

*Corresponding author. E-mail: twgeisbe@utmb.edu (T.W.G.); IMacLachlan@tekmirapharm.com (I.M.)

Published 20 August 2014, Sci. Transl. Med. 6, 250ra116 (2014)
DOI: 10.1126/scitranslmed.3009706

This PDF file includes:

  • Fig. S1. NP-718m–LNP RNAi mechanism of action confirmation.
  • Fig. S2. Clinical pathology parameters of MARV HF in NP-718m–LNP–treated, untreated, and Luc LNP–administered animals.
  • Table S1. Hematology results.
  • Table S2. Clinical chemistry results.

[Download PDF]